Research ExplorerPublicationsCost saving analysis of specialized, eHealth-based managemen...

Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study

Standard

Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study. / Eggebrecht, Lisa; Ludolph, Paul; Göbel, Sebastian; Panova-Noeva, Marina; Arnold, Natalie; Nagler, Markus; Bickel, Christoph; Lauterbach, Michael; Hardt, Roland; Cate, Hugo Ten; Lackner, Karl J; Espinola-Klein, Christine; Münzel, Thomas; Prochaska, Jürgen H; Wild, Philipp S.

In: SCI REP-UK, Vol. 11, No. 1, 2577, 28.01.2021.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

Harvard

Eggebrecht, L, Ludolph, P, Göbel, S, Panova-Noeva, M, Arnold, N, Nagler, M, Bickel, C, Lauterbach, M, Hardt, R, Cate, HT, Lackner, KJ, Espinola-Klein, C, Münzel, T, Prochaska, JH & Wild, PS 2021, 'Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study', SCI REP-UK, vol. 11, no. 1, 2577. https://doi.org/10.1038/s41598-021-82076-9

APA

Eggebrecht, L., Ludolph, P., Göbel, S., Panova-Noeva, M., Arnold, N., Nagler, M., Bickel, C., Lauterbach, M., Hardt, R., Cate, H. T., Lackner, K. J., Espinola-Klein, C., Münzel, T., Prochaska, J. H., & Wild, P. S. (2021). Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study. SCI REP-UK, 11(1), [2577]. https://doi.org/10.1038/s41598-021-82076-9

Vancouver

Eggebrecht L, Ludolph P, Göbel S, Panova-Noeva M, Arnold N, Nagler M et al. Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study. SCI REP-UK. 2021 Jan 28;11(1). 2577. https://doi.org/10.1038/s41598-021-82076-9

Bibtex

@article{6ec43796deb24ce59d78cf7e92696fbc,
title = "Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study",
abstract = "To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diagnoses (ICD-10) and operation and procedure classification system (OPS), which resulted in OAC-related (i.e. bleeding/ thromboembolic events) and non-OAC-related costs for both cohorts. Cost for anticoagulation management comprised INR-testing, personnel, and technical support. In total, 705 patients were managed by CS and 1490 patients received RMC. The number of hospital stays was significantly lower in the CS cohort compared to RMC (CS: 23.4/100 py; RMC: 68.7/100 py); with the most pronounced difference in OAC-related admissions (CS: 2.8/100 py; RMC: 13.3/100 py). Total costs for anticoagulation management amounted to 101 EUR/py in RMC and 311 EUR/py in CS, whereas hospitalization costs were 3261 [IQR 2857-3689] EUR/py in RMC and 683 [504-874] EUR/py in CS. This resulted in an overall cost saving 2368 EUR/py favoring the CS. The lower frequency of adverse events in anticoagulated patients managed by the telemedicine-based CS compared to RMC translated into a substantial cost-saving, despite higher costs for the specialized management of patients.Trial registration: ClinicalTrials.gov, unique identifier NCT01809015, March 8, 2013.",
author = "Lisa Eggebrecht and Paul Ludolph and Sebastian G{\"o}bel and Marina Panova-Noeva and Natalie Arnold and Markus Nagler and Christoph Bickel and Michael Lauterbach and Roland Hardt and Cate, {Hugo Ten} and Lackner, {Karl J} and Christine Espinola-Klein and Thomas M{\"u}nzel and Prochaska, {J{\"u}rgen H} and Wild, {Philipp S}",
year = "2021",
month = jan,
day = "28",
doi = "10.1038/s41598-021-82076-9",
language = "English",
volume = "11",
journal = "SCI REP-UK",
issn = "2045-2322",
publisher = "NATURE PUBLISHING GROUP",
number = "1",

}

RIS

TY - JOUR

T1 - Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study

AU - Eggebrecht, Lisa

AU - Ludolph, Paul

AU - Göbel, Sebastian

AU - Panova-Noeva, Marina

AU - Arnold, Natalie

AU - Nagler, Markus

AU - Bickel, Christoph

AU - Lauterbach, Michael

AU - Hardt, Roland

AU - Cate, Hugo Ten

AU - Lackner, Karl J

AU - Espinola-Klein, Christine

AU - Münzel, Thomas

AU - Prochaska, Jürgen H

AU - Wild, Philipp S

PY - 2021/1/28

Y1 - 2021/1/28

N2 - To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diagnoses (ICD-10) and operation and procedure classification system (OPS), which resulted in OAC-related (i.e. bleeding/ thromboembolic events) and non-OAC-related costs for both cohorts. Cost for anticoagulation management comprised INR-testing, personnel, and technical support. In total, 705 patients were managed by CS and 1490 patients received RMC. The number of hospital stays was significantly lower in the CS cohort compared to RMC (CS: 23.4/100 py; RMC: 68.7/100 py); with the most pronounced difference in OAC-related admissions (CS: 2.8/100 py; RMC: 13.3/100 py). Total costs for anticoagulation management amounted to 101 EUR/py in RMC and 311 EUR/py in CS, whereas hospitalization costs were 3261 [IQR 2857-3689] EUR/py in RMC and 683 [504-874] EUR/py in CS. This resulted in an overall cost saving 2368 EUR/py favoring the CS. The lower frequency of adverse events in anticoagulated patients managed by the telemedicine-based CS compared to RMC translated into a substantial cost-saving, despite higher costs for the specialized management of patients.Trial registration: ClinicalTrials.gov, unique identifier NCT01809015, March 8, 2013.

AB - To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diagnoses (ICD-10) and operation and procedure classification system (OPS), which resulted in OAC-related (i.e. bleeding/ thromboembolic events) and non-OAC-related costs for both cohorts. Cost for anticoagulation management comprised INR-testing, personnel, and technical support. In total, 705 patients were managed by CS and 1490 patients received RMC. The number of hospital stays was significantly lower in the CS cohort compared to RMC (CS: 23.4/100 py; RMC: 68.7/100 py); with the most pronounced difference in OAC-related admissions (CS: 2.8/100 py; RMC: 13.3/100 py). Total costs for anticoagulation management amounted to 101 EUR/py in RMC and 311 EUR/py in CS, whereas hospitalization costs were 3261 [IQR 2857-3689] EUR/py in RMC and 683 [504-874] EUR/py in CS. This resulted in an overall cost saving 2368 EUR/py favoring the CS. The lower frequency of adverse events in anticoagulated patients managed by the telemedicine-based CS compared to RMC translated into a substantial cost-saving, despite higher costs for the specialized management of patients.Trial registration: ClinicalTrials.gov, unique identifier NCT01809015, March 8, 2013.

U2 - 10.1038/s41598-021-82076-9

DO - 10.1038/s41598-021-82076-9

M3 - SCORING: Journal article

C2 - 33510343

VL - 11

JO - SCI REP-UK

JF - SCI REP-UK

SN - 2045-2322

IS - 1

M1 - 2577

ER -